A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : PDXs

Search Conditions:
Search Keyword : PDXs
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: PDXs
Appearance Frequency: 543 time(s)
Long forms: 12

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
patient-derived xenografts
(492 times)
Neoplasms
(204 times)
CRC (23 times)
TNBC (21 times)
NSCLC (16 times)
2012 Overcoming erlotinib resistance with tailored treatment regimen in patient-derived xenografts from naive Asian NSCLC patients.
patient-derived tumor xenografts
(38 times)
Neoplasms
(19 times)
BC (3 times)
CRC (2 times)
CSCs (2 times)
2014 Vasculature analysis of patient derived tumor xenografts using species-specific PCR assays: evidence of tumor endothelial cells and atypical VEGFA-VEGFR1/2 signalings.
patient-derived prostate cancer xenografts
(4 times)
Urology
(2 times)
EBV (1 time)
hOTEC (1 time)
PEG (1 time)
2015 Early development of human lymphomas in a prostate cancer xenograft program using triple knock-out immunocompromised mice.
panel of sarcoma cell lines and sarcoma tumor xenografts
(1 time)
Neoplasms
(1 time)
--- 2015 Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA.
patient derived ovarian xenografts
(1 time)
Neoplasms
(1 time)
BEV (1 time)
MEK (1 time)
PTX (1 time)
2017 Combination of paclitaxel, bevacizumab and MEK162 in second line treatment in platinum-relapsing patient derived ovarian cancer xenografts.
patient tumor tissue derived xenografts
(1 time)
Medicine
(1 time)
GEMMs (1 time)
2016 Development of Patient Derived Xenograft Models of Overt Spontaneous Breast Cancer Metastasis: A Cautionary Note.
patient-derived IDH1/2-mutant AML/ MDS xeno-grafts
(1 time)
Hematology
(1 time)
AML (1 time)
HR (1 time)
MDS (1 time)
2022 In vivo anti-tumor effect of PARP inhibition in IDH1/2 mutant MDS/AML resistant to targeted inhibitors of mutant IDH1/2.
Patient-derived organoids and xenografts
(1 time)
Neoplasms
(1 time)
--- 2018 Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response.
patient-derived orthotopic xenografts
(1 time)
Neoplasms
(1 time)
--- 2016 Neuroblastoma patient-derived orthotopic xenografts reflect the microenvironmental hallmarks of aggressive patient tumours.
10  patient-derived primary tumour xenografts
(1 time)
Neoplasms
(1 time)
CSCs (1 time)
2017 Metformin targets gastric cancer stem cells.
11  patient-derived xenolines
(1 time)
Biochemistry
(1 time)
GBMs (1 time)
GSCs (1 time)
IFNs (1 time)
2017 The effects of type I interferon on glioblastoma cancer stem cells.
12  plain decellularized xenografts
(1 time)
Transplantation
(1 time)
--- 2006 In vivo recellularization of plain decellularized xenografts with specific cell characterization in the systemic circulation: histological and immunohistochemical study.